GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

Meanwhile GSK is to pay $5.25 billion upfront and ... The firm says all of these franchises operate in growing markets with new and market-leading brands and products manufactured in protected ...

Laura's unparalleled expertise and insight have set a new standard for our team ... Merck, JLL, and GSK. During her years at Havas, Laura demonstrated an impressive ability to lead transformative ...

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks. Now they're getting on his nerves.

Gilead Sciences, Inc. GILD reported better-than-expected third-quarter results and raised its annual earnings guidance.

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine to prevent meningitis B, with a further candidate vaccine in late-stage development, MenABCWY. GSK intends to report ...

By enhancing DEI strategies, UK firms can set themselves apart, fostering inclusivity that drives growth – Reshma Sheikh explains As major US firms like Harley Davidson, Brown-Forman and Molson Coors ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The Clorox Company (NYSE: CLX) announced a strategic partnership with Manufacture 2030, or M2030, to help Clorox's suppliers ...

With a net cash position (including investments) over more than 10 years, Nabtesco has maintained a healthy balance sheet, in our view. As of fiscal 2023, net debt/EBITDA is at minus 1.1 and we expect ...